Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

NCT06063291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: ID110521156
DRUG: Placebo of ID110521156

Sponsor

IlDong Pharmaceutical Co Ltd

Collaborators

[object Object]